{"organizations": [], "uuid": "49f26e53181880ccf9b1590c34919f101d394ac8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "http://s.marketwatch.com/public/resources/MWimages/MW-GC659_capito_ZG_20180129174952.jpg", "site_section": "", "section_title": "", "url": "https://www.wsj.com/articles/house-approves-giving-terminally-ill-quicker-access-to-experimental-drugs-1527024798", "country": "US", "domain_rank": 387, "title": "House OKs bill giving terminal patients ‘right to try’ experimental drugs - MarketWatch", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-22T03:00:00.000+03:00", "replies_count": 0, "uuid": "49f26e53181880ccf9b1590c34919f101d394ac8"}, "author": "Stephanie Armour", "url": "https://www.wsj.com/articles/house-approves-giving-terminally-ill-quicker-access-to-experimental-drugs-1527024798", "ord_in_thread": 0, "title": "House OKs bill giving terminal patients ‘right to try’ experimental drugs - MarketWatch", "locations": [], "entities": {"persons": [{"name": "marketwatch", "sentiment": "negative"}, {"name": "ron johnson", "sentiment": "none"}, {"name": "donald trump", "sentiment": "none"}, {"name": "stephanie armour", "sentiment": "none"}, {"name": "trump", "sentiment": "none"}], "locations": [{"name": "washington", "sentiment": "none"}, {"name": "r-wis.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "house", "sentiment": "negative"}, {"name": "senate", "sentiment": "none"}, {"name": "food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "WASHINGTON—Patients with life-threatening conditions would get the right to try unproven drugs under legislation that passed Tuesday in the House and now goes to President Donald Trump, who is expected to sign it.\nThe passage of the so-called Right to Try bill, in a 250-169 vote, follows months of debate over whether expanded access to investigational drugs is compassionate or fuels false hope. The bill, sponsored by Sen. Ron Johnson (R., Wis.), passed in the Senate in August.\n... To Read the Full Story Subscribe Sign In", "external_links": [], "published": "2018-05-22T03:00:00.000+03:00", "crawled": "2018-05-23T01:45:31.048+03:00", "highlightTitle": ""}